FOX29 WFLX reports on new research showing a shift from weight loss surgery to GLP-1 medications, with insurance coverage still standing in the way for some patients.
Recap by typeshit. Post by FOX29WFLX on X.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
CME India covers an October 14 study reporting retatrutide side effects outside the gut, including a signal that the drug may paradoxically raise appetite.
Former NIGMS director Jeremy Berg walks through four decades of research behind GLP-1 drugs, from a hormone that breaks down in two minutes to weekly shots.
Loading…